Conopio, Joshua D.
HRN: 23-20-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/21/2023
06/28/2023
IV
500 Mg
Q8h
Acute Ruptured Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes